Skip to main content

Drug Eluting Stents (DES) Market Trends, Growth, Revenue Analysis and Major Key Pillars-Abbott, B. Braun Melsungen AG, Biosensors International Group, BIOTRONIK SE & Co.

Pune, India -- (SBWIRE) -- 02/17/2020 -- The Global Drug Eluting Stents (DES) Industry is estimated to generate $ 9.20 billion by 2026, growing at a CAGR of 5.35% from 2020 to 2027, according to a report by Data Bridge Market Research.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.